Showing results (271-280 of 4,768) with videos related to

Sort By:
Pageof 477
Health Policy (Amsterdam, Netherlands)|May 23, 2022
Trends in hastened death decision criteria: A review of official reportsSílvia Marina, Tony Wainwright, Helena P Pereira, et al.
Health Policy (Amsterdam, Netherlands)|December 25, 2017
Healthcare reforms in Cyprus 2013-2017: Does the crisis mark the end of the healthcare sector as we know it?Panagiotis Petrou, Sotiris Vandoros
Health Policy (Amsterdam, Netherlands)|December 2, 2017
Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoptionSuzanne Sayuri Ii, Louise Fitzgerald, Megan M Morys-Carter, et al.
Health Policy (Amsterdam, Netherlands)|October 31, 2003
Long-term follow-up and consequences for severe road traffic injuries-treatment costs and health impairment in Sweden in the 1960s and the 1990sPia Maraste, Ulf Persson, Monica Berntman
Health Policy (Amsterdam, Netherlands)|November 26, 2003
A comparison of single- and multi-payer health insurance systems and options for reformP Hussey, G F Anderson
Health Policy (Amsterdam, Netherlands)|November 26, 2003
Analysis of primary health care utilisation in south-western Finland--a tool for managementP T Ovaskainen, P T Rautava, A Ojanlatva, et al.
Health Policy (Amsterdam, Netherlands)|August 28, 2003
Towards a new welfare state: the social sustainability principle and health care strategiesJorge Garcés, Francisco Ródenas, Vicente Sanjosé
Health Policy (Amsterdam, Netherlands)|August 28, 2003
Development of integrated care in England and the Netherlands: managing across public-private boundariesIngrid Mur-Veeman, Brian Hardy, Marijke Steenbergen, et al.
Health Policy (Amsterdam, Netherlands)|August 28, 2003
Should general practitioners purchase health care for their patients? The total purchasing experiment in BritainSally Wyke, Nicholas Mays, Andrew Street, et al.
Health Policy (Amsterdam, Netherlands)|August 28, 2003
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based settingCarlo Torti, Salvatore Casari, Loredana Palvarini, et al.
Pageof 477